Home Biosimilar Antibodies Others Others antibody Ladiratuzumab (Anti-LIV-1 / SLC39A6) For research use only.
Not for use in humans.

Ladiratuzumab (Anti-LIV-1 / SLC39A6)

Synonyms: hLIV22

Ladiratuzumab (Anti-LIV-1 / SLC39A6) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. MW: 145.5 kD.

Ladiratuzumab (Anti-LIV-1 / SLC39A6)

Purity & Quality Control

Batch: A240901 Purity: 99% Protein concentration: 10.72mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Ladiratuzumab (Anti-LIV-1 / SLC39A6) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. MW: 145.5 kD.

Product Details

CAS No. 1629760-28-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ladiratuzumab (Anti-LIV-1 / SLC39A6) | Ladiratuzumab (Anti-LIV-1 / SLC39A6) supplier | purchase Ladiratuzumab (Anti-LIV-1 / SLC39A6) | Ladiratuzumab (Anti-LIV-1 / SLC39A6) cost | Ladiratuzumab (Anti-LIV-1 / SLC39A6) manufacturer | order Ladiratuzumab (Anti-LIV-1 / SLC39A6) | Ladiratuzumab (Anti-LIV-1 / SLC39A6) distributor